Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 9 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Composés actifs
Mécanisme d'action
Preuves cliniques
DLBS3233 (combined bioactive fraction of C. burmanii and L. speciosa) improved insulin resistance better than placebo, as evidenced by a reduced HOMA-IR (-27.04% vs -4.90%) [PMID:27099473].
DLBS3233 was evaluated as an add-on therapy for patients inadequately controlled by metformin and other oral antidiabetic agents to reduce HbA1c levels [PMID:27451997].
DLBS3233 was studied for its metabolic and reproductive efficacy and safety in insulin-resistant women with PCOS, comparing its effect on HOMA-IR against metformin-XR [PMID:39033369].
Ethanol extract of C. burmanii demonstrated antibiofilm effectiveness against Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in vitro [PMID:35436792].
Cinnamon extract showed potential as anti-insomnia medication in rats by decreasing the adrenal coefficient and related hormones [PMID:36317999].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 35436792 (2022) — Antimicrobial and Antibiofilm Activity of Cinnamon (Cinnamomum burmanii) Extract on Periodontal Pathogens-An in vitro study. · European journal of dentistry
- 2.PMID: 36317999 (2022) — The Potential of Cinnamon Extract (Cinnamomum burmanii) as Anti-insomnia Medication through Hypothalamus Pituitary Adrenal Axis Improvement in Rats. · Acta medica academica
- 3.PMID: 27099473 (2016) — Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa. · Drug design, development and therapy
- 4.PMID: 39033369 (2024) — The Efficacy and Safety of DLBS3233, A Combined Bioactive Fraction of Cinnamomum burmanii and Lagerstroemia speciosa Plants on The Endocrine-Metabolic Profile of Women with Polycystic Ovary Syndrome: A Randomized Clinical Trial. · International journal of fertility & sterility
- 5.PMID: 22043982